📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ISCHEMIA: new questions from a landmark trial. (2020)

First Author: Morrow A

Attributed to: MICA: A Developmental Trial of Personalised Medicine for Repurposing Zibotentan, a Selective Endothelin A Receptor Blocker, in Microvascular Angina. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cvr/cvz343

PubMed Identifier: 31942937

Publication URI: http://europepmc.org/abstract/MED/31942937

Type: Journal Article/Review

Volume: 116

Parent Publication: Cardiovascular research

Issue: 2

ISSN: 0008-6363